PMC:1310901 / 14326-15970 JSONTXT 16 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T7025 0-8 NN denotes Increase
T7026 9-11 IN denotes of
T7027 12-17 NN denotes IRF-4
T7028 18-28 NN denotes expression
T7029 29-31 IN denotes in
T7030 32-45 JJ denotes hematopoietic
T7031 46-51 NN denotes cells
T7032 52-57 IN denotes after
T7033 58-71 VB denotes demethylating
T7034 72-81 NN denotes treatment
T7035 82-84 PRP denotes We
T7036 85-89 RB denotes next
T7037 90-98 VB denotes analyzed
T7038 99-106 IN denotes whether
T7039 107-115 NN denotes promoter
T7040 116-127 NN denotes methylation
T7041 128-133 MD denotes could
T7042 134-136 VB denotes be
T7043 137-148 JJ denotes responsible
T7044 149-152 IN denotes for
T7045 153-168 NN denotes down-regulation
T7046 169-171 IN denotes of
T7047 172-177 NN denotes IRF-4
T7048 178-188 NN denotes expression
T7049 190-191 DT denotes A
T7050 192-198 NN denotes region
T7051 199-208 VB denotes including
T7052 209-214 NN denotes exon1
T7053 215-217 IN denotes in
T7054 218-221 DT denotes the
T7055 222-227 NN denotes IRF-4
T7056 228-236 NN denotes promoter
T7057 237-246 VB denotes exhibited
T7058 247-248 DT denotes a
T7059 249-254 JJ denotes large
T7060 255-261 NN denotes number
T7061 262-264 IN denotes of
T7062 265-273 JJ denotes CpG-rich
T7063 274-283 NN denotes sequences
T7064 284-285 -LRB- denotes (
T7065 285-291 NN denotes Figure
T7066 292-294 NN denotes 3A
T7067 294-295 -RRB- denotes )
T7068 297-304 JJ denotes Several
T7069 305-313 JJ denotes chemical
T7070 314-324 NN denotes substances
T7071 325-329 JJ denotes such
T7072 330-332 IN denotes as
T7073 333-354 NN denotes 5-aza-2-deoxycytidine
T7074 355-356 -LRB- denotes (
T7075 356-361 NN denotes AzadC
T7076 361-362 -RRB- denotes )
T7077 363-365 CC denotes or
T7078 366-379 NN denotes 5-azacytidine
T7079 380-381 -LRB- denotes (
T7080 381-385 NN denotes AzaC
T7081 385-386 -RRB- denotes )
T7082 387-394 VB denotes inhibit
T7083 395-397 FW denotes de
T7084 398-402 FW denotes novo
T7085 403-406 CC denotes and
T7086 407-418 NN denotes maintenance
T7087 419-430 NN denotes methylation
T7088 430-431 -COMMA- denotes ,
T7089 432-435 CC denotes and
T7090 436-440 RB denotes thus
T7091 441-444 MD denotes can
T7092 445-447 VB denotes be
T7093 448-452 VB denotes used
T7094 453-455 TO denotes to
T7095 456-463 VB denotes discern
T7096 464-472 NN denotes promoter
T7097 473-484 NN denotes methylation
T7098 485-486 -LRB- denotes (
T7099 486-491 CD denotes 32,33
T7100 491-492 -RRB- denotes )
T7101 494-496 PRP denotes We
T7102 497-501 VB denotes used
T7103 502-507 NN denotes AzadC
T7104 508-510 TO denotes to
T7105 511-519 VB denotes generate
T7106 520-532 JJ denotes unmethylated
T7107 533-536 NN denotes DNA
T7108 538-539 DT denotes A
T7109 540-542 CD denotes 72
T7110 543-544 NN denotes h
T7111 545-560 NN denotes AzadC-treatment
T7112 561-569 VB denotes resulted
T7113 570-572 IN denotes in
T7114 573-574 DT denotes a
T7115 575-598 JJ denotes concentration-dependent
T7116 599-609 NN denotes activation
T7117 610-612 IN denotes of
T7118 613-618 NN denotes IRF-4
T7119 619-632 NN denotes transcription
T7120 633-635 IN denotes in
T7121 636-642 NN denotes Jurkat
T7122 643-646 CC denotes and
T7123 647-653 NN denotes CML-T1
T7124 654-661 NN denotes T-cells
T7125 662-664 RB denotes as
T7126 665-669 RB denotes well
T7127 670-672 IN denotes as
T7128 673-675 IN denotes in
T7129 676-681 NN denotes U-937
T7130 681-682 -COMMA- denotes ,
T7131 683-688 NN denotes K-562
T7132 689-692 CC denotes and
T7133 693-697 NN denotes EM-2
T7134 698-702 NN denotes cell
T7135 703-708 NN denotes lines
T7136 709-710 -LRB- denotes (
T7137 710-716 NN denotes Figure
T7138 717-719 NN denotes 2A
T7139 719-720 -RRB- denotes )
T7140 722-727 NN denotes IRF-4
T7141 728-741 NN denotes transcription
T7142 742-745 VB denotes was
T7143 746-753 VB denotes induced
T7144 754-756 IN denotes in
T7145 757-758 DT denotes a
T7146 759-773 JJ denotes time-dependent
T7147 774-780 NN denotes manner
T7148 781-784 CC denotes and
T7149 785-788 VB denotes was
T7150 789-797 VB denotes observed
T7151 798-800 RB denotes as
T7152 801-806 RB denotes early
T7153 807-809 IN denotes as
T7154 810-812 CD denotes 24
T7155 813-814 NN denotes h
T7156 815-820 IN denotes after
T7157 821-830 NN denotes treatment
T7158 831-835 IN denotes with
T7159 836-841 NN denotes AzadC
T7160 842-845 CC denotes and
T7161 846-855 VB denotes increased
T7162 856-860 IN denotes over
T7163 861-865 NN denotes time
T7164 866-871 IN denotes until
T7165 872-874 CD denotes 72
T7166 875-876 NN denotes h
T7167 877-878 -LRB- denotes (
T7168 878-884 NN denotes Figure
T7169 885-887 NN denotes 2B
T7170 887-888 -RRB- denotes )
T7171 890-894 NN denotes Time
T7172 895-898 CC denotes and
T7173 899-907 NN denotes strength
T7174 908-910 IN denotes of
T7175 911-914 DT denotes the
T7176 915-925 NN denotes appearance
T7177 926-928 IN denotes of
T7178 929-934 NN denotes IRF-4
T7179 935-946 NN denotes transcripts
T7180 947-953 VB denotes varied
T7181 954-959 IN denotes among
T7182 960-964 NN denotes cell
T7183 965-970 NN denotes lines
T7184 970-971 -COMMA- denotes ,
T7185 972-976 FW denotes i.e.
T7186 977-983 NN denotes CML-T1
T7187 984-993 VB denotes responded
T7188 994-1003 JJ denotes strongest
T7189 1004-1006 TO denotes to
T7190 1007-1022 NN denotes AzadC-treatment
T7191 1023-1024 -LRB- denotes (
T7192 1024-1028 NN denotes data
T7193 1029-1032 RB denotes not
T7194 1033-1038 VB denotes shown
T7195 1038-1039 -RRB- denotes )
T7196 1041-1043 IN denotes In
T7197 1044-1048 NN denotes line
T7198 1049-1053 IN denotes with
T7199 1054-1058 DT denotes this
T7200 1058-1059 -COMMA- denotes ,
T7201 1060-1075 NN denotes AzadC-treatment
T7202 1076-1078 IN denotes of
T7203 1079-1085 NN denotes CML-T1
T7204 1086-1089 CC denotes and
T7205 1090-1097 NN denotes LAMA-84
T7206 1098-1103 NN denotes cells
T7207 1104-1108 RB denotes also
T7208 1109-1119 VB denotes translated
T7209 1120-1122 IN denotes in
T7210 1123-1125 DT denotes an
T7211 1126-1135 NN denotes induction
T7212 1136-1138 IN denotes of
T7213 1139-1144 NN denotes IRF-4
T7214 1145-1152 NN denotes protein
T7215 1153-1163 NN denotes expression
T7216 1164-1165 -LRB- denotes (
T7217 1165-1171 NN denotes Figure
T7218 1172-1174 NN denotes 2C
T7219 1174-1175 -RRB- denotes )
T7220 1177-1188 RB denotes Accordingly
T7221 1188-1189 -COMMA- denotes ,
T7222 1190-1199 NN denotes treatment
T7223 1200-1202 IN denotes of
T7224 1203-1206 DT denotes the
T7225 1207-1221 JJ denotes IRF-4-positive
T7226 1222-1226 NN denotes cell
T7227 1227-1231 NN denotes line
T7228 1232-1238 NN denotes BV-173
T7229 1238-1239 -COMMA- denotes ,
T7230 1240-1244 NN denotes SD-1
T7231 1245-1248 CC denotes and
T7232 1249-1258 NN denotes RPMI-8226
T7233 1259-1263 IN denotes with
T7234 1264-1269 NN denotes AzadC
T7235 1270-1273 VB denotes had
T7236 1274-1276 DT denotes no
T7237 1277-1283 NN denotes effect
T7238 1284-1286 IN denotes on
T7239 1287-1292 NN denotes IRF-4
T7240 1293-1303 NN denotes expression
T7241 1304-1305 -LRB- denotes (
T7242 1305-1311 NN denotes Figure
T7243 1312-1314 NN denotes 2D
T7244 1314-1315 -RRB- denotes )
T7245 1317-1322 EX denotes There
T7246 1323-1326 VB denotes was
T7247 1327-1329 DT denotes no
T7248 1330-1340 NN denotes difference
T7249 1341-1343 IN denotes in
T7250 1344-1347 DT denotes the
T7251 1348-1355 NN denotes effects
T7252 1356-1358 IN denotes of
T7253 1359-1363 NN denotes AzaC
T7254 1364-1370 IN denotes versus
T7255 1371-1376 NN denotes AzadC
T7256 1376-1377 -COMMA- denotes ,
T7257 1378-1380 IN denotes as
T7258 1381-1385 DT denotes both
T7259 1386-1395 VB denotes increased
T7260 1396-1399 DT denotes the
T7261 1400-1405 NN denotes IRF-4
T7262 1406-1410 NN denotes mRNA
T7263 1411-1416 NN denotes level
T7264 1417-1419 IN denotes in
T7265 1420-1426 NN denotes CML-T1
T7266 1427-1432 NN denotes cells
T7267 1433-1435 RB denotes as
T7268 1436-1440 RB denotes well
T7269 1441-1442 -LRB- denotes (
T7270 1442-1446 NN denotes data
T7271 1447-1450 RB denotes not
T7272 1451-1456 VB denotes shown
T7273 1456-1457 -RRB- denotes )
T7274 1459-1463 DT denotes This
T7275 1464-1471 VB denotes implied
T7276 1472-1476 IN denotes that
T7277 1477-1485 NN denotes promoter
T7278 1486-1497 NN denotes methylation
T7279 1498-1501 MD denotes may
T7280 1502-1509 VB denotes control
T7281 1510-1515 NN denotes IRF-4
T7282 1516-1526 NN denotes expression
T7283 1526-1527 -COMMA- denotes ,
T7284 1528-1531 CC denotes but
T7285 1532-1534 DT denotes an
T7286 1535-1546 JJ denotes alternative
T7287 1547-1558 NN denotes explanation
T7288 1559-1562 MD denotes may
T7289 1563-1565 VB denotes be
T7290 1566-1576 NN denotes activation
T7291 1577-1579 IN denotes of
T7292 1580-1588 JJ denotes positive
T7293 1589-1604 JJ denotes transcriptional
T7294 1605-1615 NN denotes regulators
T7295 1616-1618 IN denotes of
T7296 1619-1624 NN denotes IRF-4
T7297 1625-1627 IN denotes by
T7298 1628-1633 NN denotes AzadC
T7299 1634-1635 -LRB- denotes (
T7300 1635-1637 CC denotes or
T7301 1638-1642 NN denotes AzaC
T7302 1642-1643 -RRB- denotes )
R5814 T7025 T7026 arg1Of Increase,of
R5815 T7025 T7029 arg1Of Increase,in
R5816 T7025 T7032 arg1Of Increase,after
R5817 T7028 T7026 arg2Of expression,of
R5818 T7028 T7027 arg1Of expression,IRF-4
R5819 T7031 T7029 arg2Of cells,in
R5820 T7031 T7030 arg1Of cells,hematopoietic
R5821 T7033 T7032 arg2Of demethylating,after
R5822 T7034 T7033 arg2Of treatment,demethylating
R5823 T7035 T7037 arg1Of We,analyzed
R5824 T7037 T7036 arg1Of analyzed,next
R5825 T7040 T7039 arg1Of methylation,promoter
R5826 T7040 T7041 arg1Of methylation,could
R5827 T7040 T7042 arg1Of methylation,be
R5828 T7040 T7043 arg1Of methylation,responsible
R5829 T7042 T7037 arg2Of be,analyzed
R5830 T7042 T7038 arg1Of be,whether
R5831 T7042 T7041 arg2Of be,could
R5832 T7043 T7042 arg2Of responsible,be
R5833 T7043 T7044 arg1Of responsible,for
R5834 T7045 T7044 arg2Of down-regulation,for
R5835 T7045 T7046 arg1Of down-regulation,of
R5836 T7048 T7046 arg2Of expression,of
R5837 T7048 T7047 arg1Of expression,IRF-4
R5838 T7050 T7049 arg1Of region,A
R5839 T7050 T7051 arg1Of region,including
R5840 T7050 T7057 arg1Of region,exhibited
R5841 T7052 T7051 arg2Of exon1,including
R5842 T7052 T7053 arg1Of exon1,in
R5843 T7056 T7053 arg2Of promoter,in
R5844 T7056 T7054 arg1Of promoter,the
R5845 T7056 T7055 arg1Of promoter,IRF-4
R5846 T7060 T7057 arg2Of number,exhibited
R5847 T7060 T7058 arg1Of number,a
R5848 T7060 T7059 arg1Of number,large
R5849 T7060 T7061 arg1Of number,of
R5850 T7063 T7061 arg2Of sequences,of
R5851 T7063 T7062 arg1Of sequences,CpG-rich
R5852 T7063 T7064 arg1Of sequences,(
R5853 T7066 T7064 arg2Of 3A,(
R5854 T7066 T7065 arg1Of 3A,Figure
R5855 T7067 T7064 arg3Of ),(
R5856 T7070 T7068 arg1Of substances,Several
R5857 T7070 T7069 arg1Of substances,chemical
R5858 T7070 T7072 arg1Of substances,as
R5859 T7070 T7082 arg1Of substances,inhibit
R5860 T7070 T7091 arg1Of substances,can
R5861 T7070 T7092 arg1Of substances,be
R5862 T7070 T7093 arg2Of substances,used
R5863 T7072 T7071 arg1Of as,such
R5864 T7073 T7074 arg1Of 5-aza-2-deoxycytidine,(
R5865 T7073 T7077 arg1Of 5-aza-2-deoxycytidine,or
R5866 T7075 T7074 arg2Of AzadC,(
R5867 T7076 T7074 arg3Of ),(
R5868 T7077 T7072 arg2Of or,as
R5869 T7078 T7077 arg2Of 5-azacytidine,or
R5870 T7078 T7079 arg1Of 5-azacytidine,(
R5871 T7080 T7079 arg2Of AzaC,(
R5872 T7081 T7079 arg3Of ),(
R5873 T7082 T7089 arg1Of inhibit,and
R5874 T7084 T7083 arg1Of novo,de
R5875 T7087 T7082 arg2Of methylation,inhibit
R5876 T7087 T7084 arg1Of methylation,novo
R5877 T7087 T7085 arg1Of methylation,and
R5878 T7087 T7086 arg1Of methylation,maintenance
R5879 T7089 T7088 arg1Of and,","
R5880 T7093 T7089 arg2Of used,and
R5881 T7093 T7090 arg1Of used,thus
R5882 T7093 T7091 arg2Of used,can
R5883 T7093 T7092 arg2Of used,be
R5884 T7095 T7093 arg3Of discern,used
R5885 T7095 T7094 arg1Of discern,to
R5886 T7097 T7095 arg2Of methylation,discern
R5887 T7097 T7096 arg1Of methylation,promoter
R5888 T7097 T7098 arg1Of methylation,(
R5889 T7099 T7098 arg2Of "32,33",(
R5890 T7100 T7098 arg3Of ),(
R5891 T7101 T7102 arg1Of We,used
R5892 T7101 T7105 arg1Of We,generate
R5893 T7103 T7102 arg2Of AzadC,used
R5894 T7105 T7102 arg3Of generate,used
R5895 T7105 T7104 arg1Of generate,to
R5896 T7107 T7105 arg2Of DNA,generate
R5897 T7107 T7106 arg1Of DNA,unmethylated
R5898 T7111 T7108 arg1Of AzadC-treatment,A
R5899 T7111 T7109 arg1Of AzadC-treatment,72
R5900 T7111 T7110 arg1Of AzadC-treatment,h
R5901 T7111 T7112 arg1Of AzadC-treatment,resulted
R5902 T7112 T7113 arg1Of resulted,in
R5903 T7112 T7128 arg1Of resulted,in
R5904 T7113 T7127 arg1Of in,as
R5905 T7116 T7113 arg2Of activation,in
R5906 T7116 T7114 arg1Of activation,a
R5907 T7116 T7115 arg1Of activation,concentration-dependent
R5908 T7116 T7117 arg1Of activation,of
R5909 T7116 T7120 arg1Of activation,in
R5910 T7119 T7117 arg2Of transcription,of
R5911 T7119 T7118 arg1Of transcription,IRF-4
R5912 T7121 T7122 arg1Of Jurkat,and
R5913 T7123 T7122 arg2Of CML-T1,and
R5914 T7124 T7120 arg2Of T-cells,in
R5915 T7124 T7121 arg1Of T-cells,Jurkat
R5916 T7124 T7123 arg1Of T-cells,CML-T1
R5917 T7127 T7125 arg1Of as,as
R5918 T7127 T7126 arg1Of as,well
R5919 T7128 T7127 arg2Of in,as
R5920 T7129 T7130 arg1Of U-937,","
R5921 T7130 T7132 arg1Of ",",and
R5922 T7131 T7130 arg2Of K-562,","
R5923 T7132 T7128 arg2Of and,in
R5924 T7135 T7132 arg2Of lines,and
R5925 T7135 T7133 arg1Of lines,EM-2
R5926 T7135 T7134 arg1Of lines,cell
R5927 T7135 T7136 arg1Of lines,(
R5928 T7138 T7136 arg2Of 2A,(
R5929 T7138 T7137 arg1Of 2A,Figure
R5930 T7139 T7136 arg3Of ),(
R5931 T7141 T7140 arg1Of transcription,IRF-4
R5932 T7141 T7142 arg1Of transcription,was
R5933 T7141 T7143 arg2Of transcription,induced
R5934 T7141 T7149 arg1Of transcription,was
R5935 T7141 T7150 arg2Of transcription,observed
R5936 T7141 T7161 arg1Of transcription,increased
R5937 T7143 T7142 arg2Of induced,was
R5938 T7143 T7144 arg1Of induced,in
R5939 T7143 T7148 arg1Of induced,and
R5940 T7147 T7144 arg2Of manner,in
R5941 T7147 T7145 arg1Of manner,a
R5942 T7147 T7146 arg1Of manner,time-dependent
R5943 T7150 T7149 arg2Of observed,was
R5944 T7150 T7152 arg1Of observed,early
R5945 T7150 T7156 arg1Of observed,after
R5946 T7150 T7160 arg1Of observed,and
R5947 T7152 T7151 arg1Of early,as
R5948 T7152 T7153 arg1Of early,as
R5949 T7155 T7153 arg2Of h,as
R5950 T7155 T7154 arg1Of h,24
R5951 T7157 T7156 arg2Of treatment,after
R5952 T7157 T7158 arg1Of treatment,with
R5953 T7159 T7158 arg2Of AzadC,with
R5954 T7160 T7148 arg2Of and,and
R5955 T7161 T7160 arg2Of increased,and
R5956 T7161 T7162 arg1Of increased,over
R5957 T7161 T7164 arg1Of increased,until
R5958 T7163 T7162 arg2Of time,over
R5959 T7166 T7164 arg2Of h,until
R5960 T7166 T7165 arg1Of h,72
R5961 T7166 T7167 arg1Of h,(
R5962 T7169 T7167 arg2Of 2B,(
R5963 T7169 T7168 arg1Of 2B,Figure
R5964 T7170 T7167 arg3Of ),(
R5965 T7171 T7172 arg1Of Time,and
R5966 T7172 T7174 arg1Of and,of
R5967 T7172 T7180 arg1Of and,varied
R5968 T7173 T7172 arg2Of strength,and
R5969 T7176 T7174 arg2Of appearance,of
R5970 T7176 T7175 arg1Of appearance,the
R5971 T7176 T7177 arg1Of appearance,of
R5972 T7179 T7177 arg2Of transcripts,of
R5973 T7179 T7178 arg1Of transcripts,IRF-4
R5974 T7180 T7181 arg1Of varied,among
R5975 T7180 T7184 arg1Of varied,","
R5976 T7183 T7181 arg2Of lines,among
R5977 T7183 T7182 arg1Of lines,cell
R5978 T7186 T7185 arg1Of CML-T1,i.e.
R5979 T7186 T7187 arg1Of CML-T1,responded
R5980 T7187 T7184 arg2Of responded,","
R5981 T7187 T7189 arg1Of responded,to
R5982 T7188 T7187 arg2Of strongest,responded
R5983 T7190 T7189 arg2Of AzadC-treatment,to
R5984 T7190 T7191 arg1Of AzadC-treatment,(
R5985 T7192 T7191 arg2Of data,(
R5986 T7192 T7194 arg2Of data,shown
R5987 T7194 T7193 arg1Of shown,not
R5988 T7195 T7191 arg3Of ),(
R5989 T7197 T7196 arg2Of line,In
R5990 T7197 T7198 arg1Of line,with
R5991 T7199 T7198 arg2Of this,with
R5992 T7201 T7202 arg1Of AzadC-treatment,of
R5993 T7201 T7208 arg1Of AzadC-treatment,translated
R5994 T7203 T7204 arg1Of CML-T1,and
R5995 T7205 T7204 arg2Of LAMA-84,and
R5996 T7206 T7202 arg2Of cells,of
R5997 T7206 T7203 arg1Of cells,CML-T1
R5998 T7206 T7205 arg1Of cells,LAMA-84
R5999 T7208 T7196 arg1Of translated,In
R6000 T7208 T7200 arg1Of translated,","
R6001 T7208 T7207 arg1Of translated,also
R6002 T7208 T7209 arg1Of translated,in
R6003 T7211 T7209 arg2Of induction,in
R6004 T7211 T7210 arg1Of induction,an
R6005 T7211 T7212 arg1Of induction,of
R6006 T7215 T7212 arg2Of expression,of
R6007 T7215 T7213 arg1Of expression,IRF-4
R6008 T7215 T7214 arg1Of expression,protein
R6009 T7215 T7216 arg1Of expression,(
R6010 T7218 T7216 arg2Of 2C,(
R6011 T7218 T7217 arg1Of 2C,Figure
R6012 T7219 T7216 arg3Of ),(
R6013 T7222 T7223 arg1Of treatment,of
R6014 T7222 T7229 arg1Of treatment,","
R6015 T7228 T7223 arg2Of BV-173,of
R6016 T7228 T7224 arg1Of BV-173,the
R6017 T7228 T7225 arg1Of BV-173,IRF-4-positive
R6018 T7228 T7226 arg1Of BV-173,cell
R6019 T7228 T7227 arg1Of BV-173,line
R6020 T7229 T7235 arg1Of ",",had
R6021 T7230 T7231 arg1Of SD-1,and
R6022 T7231 T7229 arg2Of and,","
R6023 T7231 T7233 arg1Of and,with
R6024 T7232 T7231 arg2Of RPMI-8226,and
R6025 T7234 T7233 arg2Of AzadC,with
R6026 T7235 T7220 arg1Of had,Accordingly
R6027 T7235 T7221 arg1Of had,","
R6028 T7237 T7235 arg2Of effect,had
R6029 T7237 T7236 arg1Of effect,no
R6030 T7237 T7238 arg1Of effect,on
R6031 T7240 T7238 arg2Of expression,on
R6032 T7240 T7239 arg1Of expression,IRF-4
R6033 T7240 T7241 arg1Of expression,(
R6034 T7243 T7241 arg2Of 2D,(
R6035 T7243 T7242 arg1Of 2D,Figure
R6036 T7244 T7241 arg3Of ),(
R6037 T7245 T7246 arg1Of There,was
R6038 T7246 T7249 arg1Of was,in
R6039 T7246 T7256 arg1Of was,","
R6040 T7246 T7257 arg1Of was,as
R6041 T7248 T7246 arg2Of difference,was
R6042 T7248 T7247 arg1Of difference,no
R6043 T7251 T7249 arg2Of effects,in
R6044 T7251 T7250 arg1Of effects,the
R6045 T7251 T7252 arg1Of effects,of
R6046 T7253 T7252 arg2Of AzaC,of
R6047 T7253 T7254 arg1Of AzaC,versus
R6048 T7255 T7254 arg2Of AzadC,versus
R6049 T7258 T7259 arg1Of both,increased
R6050 T7259 T7257 arg2Of increased,as
R6051 T7259 T7267 arg1Of increased,as
R6052 T7263 T7259 arg2Of level,increased
R6053 T7263 T7260 arg1Of level,the
R6054 T7263 T7261 arg1Of level,IRF-4
R6055 T7263 T7262 arg1Of level,mRNA
R6056 T7263 T7264 arg1Of level,in
R6057 T7266 T7264 arg2Of cells,in
R6058 T7266 T7265 arg1Of cells,CML-T1
R6059 T7268 T7267 arg2Of well,as
R6060 T7268 T7269 arg1Of well,(
R6061 T7270 T7269 arg2Of data,(
R6062 T7270 T7272 arg2Of data,shown
R6063 T7272 T7271 arg1Of shown,not
R6064 T7273 T7269 arg3Of ),(
R6065 T7274 T7275 arg1Of This,implied
R6066 T7278 T7277 arg1Of methylation,promoter
R6067 T7278 T7279 arg1Of methylation,may
R6068 T7278 T7280 arg1Of methylation,control
R6069 T7280 T7279 arg2Of control,may
R6070 T7280 T7284 arg1Of control,but
R6071 T7282 T7280 arg2Of expression,control
R6072 T7282 T7281 arg1Of expression,IRF-4
R6073 T7284 T7275 arg2Of but,implied
R6074 T7284 T7276 arg1Of but,that
R6075 T7284 T7283 arg1Of but,","
R6076 T7287 T7285 arg1Of explanation,an
R6077 T7287 T7286 arg1Of explanation,alternative
R6078 T7287 T7288 arg1Of explanation,may
R6079 T7287 T7289 arg1Of explanation,be
R6080 T7289 T7284 arg2Of be,but
R6081 T7289 T7288 arg2Of be,may
R6082 T7289 T7297 arg1Of be,by
R6083 T7290 T7289 arg2Of activation,be
R6084 T7290 T7291 arg1Of activation,of
R6085 T7294 T7291 arg2Of regulators,of
R6086 T7294 T7292 arg1Of regulators,positive
R6087 T7294 T7293 arg1Of regulators,transcriptional
R6088 T7294 T7295 arg1Of regulators,of
R6089 T7296 T7295 arg2Of IRF-4,of
R6090 T7298 T7297 arg2Of AzadC,by
R6091 T7298 T7299 arg1Of AzadC,(
R6092 T7301 T7299 arg2Of AzaC,(
R6093 T7301 T7300 arg1Of AzaC,or
R6094 T7302 T7299 arg3Of ),(